Cargando…
D‐dimer testing in clinical practice in the era of COVID‐19
D‐dimer is a fragment of crosslinked fibrin resulting from plasmin cleavage of fibrin clots and hence an indirect biomarker of the hemostatic system activation. Early in the coronavirus disease 2019 (COVID‐19) pandemic, several studies described coagulation disorders in affected patients, including...
Autores principales: | Auditeau, Claire, Khider, Lina, Planquette, Benjamin, Sanchez, Olivier, Smadja, David M., Gendron, Nicolas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9133433/ https://www.ncbi.nlm.nih.gov/pubmed/35664536 http://dx.doi.org/10.1002/rth2.12730 |
Ejemplares similares
-
Intramuscular Vaccination in Adults with Therapeutic Anticoagulation in the Era of COVID-19 Vaccines Outbreak: A Practical Review
por: Perrin, Germain, et al.
Publicado: (2021) -
Inherited Thrombophilia in the Era of Direct Oral Anticoagulants
por: Khider, Lina, et al.
Publicado: (2022) -
Predictive Factor for COVID-19 Worsening: Insights for High-Sensitivity Troponin and D-Dimer and Correlation With Right Ventricular Afterload
por: Goudot, Guillaume, et al.
Publicado: (2020) -
Adjusting D-dimer to Lung Disease Extent to Exclude Pulmonary Embolism in COVID-19 Patients (Co-LEAD)
por: Planquette, Benjamin, et al.
Publicado: (2022) -
Systematic search for the UBA1 mutation in men after a first episode of venous thromboembolism: A monocentric study
por: Khider, Lina, et al.
Publicado: (2022)